Theravance Biopharma (TBPH) Stock Boasts a 35% Upside

We don't have a long history of data to work with, but we like the upside in Theravance Biopharma's (TBPH) stock chart.
By Bruce Kamich ,

NEW YORK (TheStreet) -- We don't have a long history of data to work with, but we like what we see for Theravance Biopharma (TBPH) - Get Report .

In this chart, above, we see a number of bullish technical clues. First, we have a five-month bottom process. TBPH has rallied over the 50-day Moving Average (MA) and now the slope of that average is positive. The On-Balance-Volume (OBV) is rising. Last, we can see the Moving Average Convergence Divergence (MACD) oscillator is in a bullish position and above the zero line.

We don't have a lot more data in this chart, above, but we can see that prices are above the 40-week MA, the OBV line is inching higher and the MACD oscillator has made a bullish crossover and is heading up to cross the zero line.

Our strategy would be to go long TBPH here using a sell stop at $13.99 and plugging in a $22 price target.

Loading ...